PREMIER FOODS P/ADR (OTCMKTS:PRRFY) and ORION OYJ/ADR (OTCMKTS:ORINY) are both consumer staples companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.
Valuation & Earnings
This table compares PREMIER FOODS P/ADR and ORION OYJ/ADR’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|PREMIER FOODS P/ADR||$1.08 billion||0.75||-$44.37 million||$0.56||8.63|
|ORION OYJ/ADR||$1.18 billion||5.93||$224.45 million||$0.80||30.88|
This is a breakdown of current recommendations and price targets for PREMIER FOODS P/ADR and ORION OYJ/ADR, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|PREMIER FOODS P/ADR||0||0||1||0||3.00|
Risk & Volatility
PREMIER FOODS P/ADR has a beta of 3.49, indicating that its stock price is 249% more volatile than the S&P 500. Comparatively, ORION OYJ/ADR has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500.
This table compares PREMIER FOODS P/ADR and ORION OYJ/ADR’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|PREMIER FOODS P/ADR||N/A||N/A||N/A|
ORION OYJ/ADR beats PREMIER FOODS P/ADR on 8 of the 10 factors compared between the two stocks.
PREMIER FOODS P/ADR Company Profile
There is no company description available for Premier Foods PLC.
ORION OYJ/ADR Company Profile
Orion Oyj engages in the development and manufacture of pharmaceuticals, active pharmaceutical ingredients (APIs), and diagnostic tests worldwide. The company operates in two segments, Pharmaceuticals and Diagnostics. The Pharmaceuticals segment develops, manufactures, and markets pharmaceuticals and APIs. This segment provides proprietary drugs in the areas of central nervous system, oncology and critical care, and pulmonary care; generic prescription drugs, as well as self-care products, such as non-prescription medicines, basic ointments, and vitamins; proprietary and generic veterinary drugs; and APIs for generic and proprietary drugs, as well as offers contract manufacturing services for APIs. This segment also markets and sells veterinary drugs manufactured by other international companies. The Diagnostics segment develops, manufactures, and markets in vitro diagnostic test systems and tests for diagnosing diseases and monitoring treatment efficacy. Orion Oyj has a strategic alliance with Novan, Inc. to manufacture topical nitric oxide-releasing product candidates; and research collaboration with Fifth Corner Inc. to seek solutions to improve the quality of life of prostate cancer patients. The company was founded in 1917 and is headquartered in Espoo, Finland.
Receive News & Ratings for PREMIER FOODS P/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PREMIER FOODS P/ADR and related companies with MarketBeat.com's FREE daily email newsletter.